| Magnetic Resonance TIP - MRI Database : Dotarem Description, information and specification (compound, contrast effect, relaxivity, etc.), further resources and news for the MRI contrast agent/media Dotarem from ... Read More |
| Dotarem® - Guerbet Asia Pacific - Home Gd-DOTA content. Density at 20° C. Osmolality mOsm/kg H 2 O. Viscosity mPa.s at 20° C. Viscosity mPa.s at 37° C. pH. Dotarem® 27.93% m/v. 1.1739 g/cm3. 1 350. 3.2 Read More |
| Dotarem - Drugs.com Dotarem is a medicine available in a number of countries worldwide. A list of US medications equivalent to Dotarem is available on the Drugs.com website. Read More |
| The MRI contrast agent Dotarem® - Danish Medicines Agency Dotarem® is a gadolinium-containing contrast agent used in connection with MRI scanning. Gadolinium-containing contrast agents must be used with extreme care when ... Read More |
| DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in ... DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases Read More |
| Nephrogenic systemic fibrosis - Wikipedia, the free encyclopedia Least likely (safest) to release free gadolinium ions Gd 3+ in the body have a cyclical structure: Dotarem, Gadovist and ProHance; Intermediate have an ionic linear structure: ... Read More |
| Gadoteric acid - Wikipedia, the free encyclopedia Gadoteric acid (trade names Artirem, Dotarem) is a macrocycle -structured gadolinium-based MRI contrast agent. It consists of the organic acid DOTA as a chelating ... Read More |
| Magnetic Resonance TIP - MRI Database : Dotarem® This page contains information, links to basics and news resources about Dotarem , furthermore the related entries: Artirem, Extracellular Fluid Agents, Gadolinium ... Read More |
| Pharmaceutical Form Data Sheet Page 1 of 7 Dotarem Gadoteric Acid, 0.5 mmol/mL, solution for injection Contrast media agent Pharmaceutical Form Solution for injection in bottles and pre ... Read More |
| Renal Safety Evaluation After Dotarem-enhanced MRI - Full Text ... Although there is a well documented risk of acute renal failure with the iodinated contrast agents, intravenous gadolinium-based contrast agents are considered non ... Read More |
